InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,429.72
(
-1.68%
)
US TECH 100
18,332.00
(
-2.71%
)
Dow Jones
40,210.28
(
-1.55%
)
Brent Oil
80.20
(
-1.61%
)
Bitcoin
63,242.59
(
-2.11%
)
Post# of 346155
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pphmtoolong

Send PM Follow Ignore
Followers 27
Posts 3416
Boards Moderated 0
Alias Born 07/17/2006

pphmtoolong

Re: None

Monday, 04/16/2007 12:44:19 PM

Monday, April 16, 2007 12:44:19 PM

Post# of 346155
So add 2C3, or 3R as the fully humanized version apparently is knownn, to Bavituximab. Two really hot prospects.

I found it interesting that the PR directly took on Avastin. Pretty bold for our little Tustin company.

Stay tuned, the best is yet to be.

Paul
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM

Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM

VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM

Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM

Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM

Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!